Published online before print June 26, 2006, doi: 10.1161/01.HYP.0000231552.10054.aa
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;48:219.)
© 2006 American Heart Association, Inc.
Original Articles |
Thiazide Diuretics, Potassium, and the Development of Diabetes
A Quantitative Review
From the Purdue University College of Pharmacy (A.J.Z.), Department of Pharmacy Practice, West Lafayette, Ind; Department of Medicine (J.G.), Division of Nephrology, University of California-San Francisco; Division of Statistics (S.B.), Northern Illinois University, De Kalb; Preventive Medicine and Internal Medicine (G.L.B.), Hypertension/Clinical Research Center, Rush University Medical Center, Chicago, Ill; Division of Clinical and Administrative Pharmacy (B.L.C.), College of Pharmacy, Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Correspondence to Barry L. Carter, University of Iowa College of Pharmacy, 115 S Grand Ave, Iowa City, IA 52242. E-mail barry-carter{at}uiowa.edu
National guidelines and a recent clinical trial have supported the use of thiazide diuretics as the preferred initial pharmacological treatment for hypertension. However, evidence from this and other clinical trials have also found an increased incidence of new onset diabetes among those patients receiving thiazide diuretics. The mechanisms responsible for the increased incidence of diabetes with thiazide diuretics have not been fully elucidated. This article provides a review of intervention studies that included data on the relation between thiazide-induced hypokalemia and glucose intolerance. We conducted a literature search from 1966 to June 2004 to identify clinical trials using thiazide diuretics where the metabolic effects on potassium and glucose are reported. A total of 59 clinical trials constituting 83 thiazide diuretic study arms were identified. Trial size, length, type of thiazide diuretic, and dose varied substantially among the studies. The association between average changes in potassium and glucose in the study arms is considered jointly in a weighted statistical model. The Pearson’s correlation coefficient, weighted by study sample size, for the relationship between glucose and potassium was –0.54 (95% CI, –0.67 to –0.36; P<0.01). A sensitivity analysis, which considered subset analyses and effect of covariates, as well as inverse-variance weighting, supported this finding. These data suggest that thiazide-induced hypokalemia is associated with increased blood glucose. Treatment of thiazide-induced hypokalemia may reverse glucose intolerance and possibly prevent the future development of diabetes.
Key Words: diuretics • potassium • glucose • diabetes mellitus • hypertension, experimental
Related Article:
Hypertension 2006 48: 198-200.
This article has been cited by other articles:
 |
|
 |
|
  M. Greenlee, C. S. Wingo, A. A. McDonough, J.-H. Youn, and B. C. Kone Narrative Review: Evolving Concepts in Potassium Homeostasis and Hypokalemia Ann Intern Med, May 5, 2009; 150(9): 619 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pimenta and D. A. Calhoun Aldosterone and Metabolic Dysfunction: An Unresolved Issue Hypertension, April 1, 2009; 53(4): 585 - 586. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Cooper-DeHoff, M. A. Pacanowski, and C. J. Pepine Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S28 - S34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Schmieder, T. Philipp, J. Guerediaga, M. Gorostidi, B. Smith, N. Weissbach, M. Maboudian, J. Botha, and H. van Ingen Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren: A 12-Month Randomized, Double-Blind Comparator Trial With Hydrochlorothiazide Circulation, January 27, 2009; 119(3): 417 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shafi, L. J. Appel, E. R. Miller III, M. J. Klag, and R. S. Parekh Changes in Serum Potassium Mediate Thiazide-Induced Diabetes Hypertension, December 1, 2008; 52(6): 1022 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dronavalli and G. L. Bakris Mechanistic Insights into Diuretic-Induced Insulin Resistance Hypertension, December 1, 2008; 52(6): 1009 - 1011. [Full Text] [PDF]
|
|
|
|
|
|
R. Agarwal Hypertension, Hypokalemia, and Thiazide-Induced Diabetes: A 3-Way Connection Hypertension, December 1, 2008; 52(6): 1012 - 1013. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M Stewart, A. Stears, J. W Tomlinson, and M. J Brown Regulation--the real threat to clinical research BMJ, October 16, 2008; 337(oct16_2): a1732 - a1732. [Full Text]
|
|
|
|
|
|
B. L. Carter, P. T. Einhorn, M. Brands, J. He, J. A. Cutler, P. K. Whelton, G. L. Bakris, F. L. Brancati, W. C. Cushman, S. Oparil, et al. Thiazide-Induced Dysglycemia: Call for Research From a Working Group From the National Heart, Lung, and Blood Institute Hypertension, July 1, 2008; 52(1): 30 - 36. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Cutler and B. R. Davis Thiazide-Type Diuretics and {beta}-Adrenergic Blockers as First-Line Drug Treatments for Hypertension Circulation, May 20, 2008; 117(20): 2691 - 2705. [Full Text] [PDF]
|
|
|
|
|
|
B. Williams The Year in Hypertension J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Neilson The Fructose Nation J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2619 - 2621. [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Chobanian Isolated Systolic Hypertension in the Elderly N. Engl. J. Med., August 23, 2007; 357(8): 789 - 796. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]
|
|
|
|
|
|
H. J. Adrogue and N. E. Madias Sodium and Potassium in the Pathogenesis of Hypertension N. Engl. J. Med., May 10, 2007; 356(19): 1966 - 1978. [Full Text] [PDF]
|
|
|
|
|
|
J. Jordan, S. Engeli, S. W. Boye, S. Le Breton, and D. L. Keefe Direct Renin Inhibition With Aliskiren in Obese Patients With Arterial Hypertension Hypertension, May 1, 2007; 49(5): 1047 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bangalore, F. H. Messerli, B. J. Potter, J. LeLorier, B. J. Epstein, R. M. Cooper-DeHoff, J. Bosch, S. Yusuf, and H. Gerstein Effect of Ramipril on the Incidence of Diabetes N. Engl. J. Med., February 1, 2007; 356(5): 522 - 524. [Full Text] [PDF]
|
|
|
|
|
|
N. M. Kaplan Clinical Trials for Hypertension: Expectations Fulfilled and Unfulfilled Hypertension, February 1, 2007; 49(2): 257 - 259. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bakris, M. Molitch, A. Hewkin, M. Kipnes, P. Sarafidis, K. Fakouhi, P. Bacher, J. Sowers, and on behalf of the STAR Investigators Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome Diabetes Care, December 1, 2006; 29(12): 2592 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Barzilay, B. R. Davis, J. A. Cutler, S. L. Pressel, P. K. Whelton, J. Basile, K. L. Margolis, S. T. Ong, L. S. Sadler, J. Summerson, et al. Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med, November 13, 2006; 166(20): 2191 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Minerva BMJ, August 12, 2006; 333(7563): 360 - 360. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Cutler Thiazide-Associated Glucose Abnormalities: Prognosis, Etiology, and Prevention: Is Potassium Balance the Key? Hypertension, August 1, 2006; 48(2): 198 - 200. [Full Text] [PDF]
|
|